Results 1 to 10 of about 842,627 (287)

Prediction of the Presence of Targetable Molecular Alteration(s) with Clinico-Metabolic 18 F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients [PDF]

open access: yesDiagnostics, 2022
This study aimed to investigate if combining clinical characteristics with pre-therapeutic 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography (PET) radiomics could predict the presence of molecular alteration(s) in key molecular targets in ...
Nicolas Aide   +2 more
doaj   +2 more sources

Molecular alteration patterns predict tumor behavior in papillary thyroid carcinoma independent of tumor size: insights from an international multicenter retrospective study [PDF]

open access: yesThyroid Research
Background Molecular testing is a well-established tool that assists in the management of thyroid nodules and allows classification in distinct molecular alteration patterns: BRAF-like, RAS-like and non-BRAF-non-RAS (NBNR).
Grégoire B. Morand   +9 more
doaj   +2 more sources

Deciphering the Clinical Implications of Concurrent Chromosome 7 Gain and Chromosome 10 Loss in Glioblastoma: A Scoping Review [PDF]

open access: yesBrain Sciences
Background/Objectives: Combined chromosome 7 gain and chromosome 10 loss (+7/−10) is the most frequent cytogenetic alteration and a defining diagnostic criterion for isocitrate dehydrogenase wild-type (IDHwt) glioblastoma.
Edgar G. Ordóñez-Rubiano   +12 more
doaj   +2 more sources

Integrated proteome, phospho-proteome and malonyl-proteome revealed a molecular alteration of breast cancer [PDF]

open access: yesScientific Reports
Breast cancer is a heterogeneous disease with a high incidence, but its proteomes have not yet been thoroughly characterized. To construct a comprehensive dynamic network of breast cancer-related proteins, we integrated the whole-cell proteome (WCP ...
Chenxu Guo   +6 more
doaj   +2 more sources

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors

open access: yesFrontiers in Oncology, 2023
BackgroundThe 5th edition of the World Health Organization (WHO) classification of central nervous system tumors incorporated specific molecular alterations into the categorization of gliomas.
Xiaopeng Guo   +37 more
doaj   +1 more source

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors

open access: yesFrontiers in Oncology, 2023
IntroductionGlioblastoma (GBM), the most lethal primary brain malignancy, is divided into histological (hist-GBM) and molecular (mol-GBM) subtypes according to the 2021 World Health Organization classification of central nervous system tumors. This study
Xiaopeng Guo   +41 more
doaj   +1 more source

Enhancing the Catalytic Performance of Candida antarctica Lipase B by Chemical Modification With Alkylated Betaine Ionic Liquids

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Various betaine ionic liquids composed of different chain lengths and different anions were designed and synthesized to modify Candida antarctica lipase B (CALB).
Yu Xue   +5 more
doaj   +1 more source

Theileria infection in bullfighting cattle in Thailand [PDF]

open access: yesVeterinary World, 2022
Background and Aim: An apicomplexan protozoan parasite, namely, Theileria, primarily causes theileriosis in cattle worldwide. The virulence of the disease has been neglected because of it's low pathogenicity.
Pirayu Rakwong   +3 more
doaj   +1 more source

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors

open access: yesCancer Medicine, 2023
Background The latest fifth edition of the World Health Organization (WHO) classification of the central nervous system (CNS) tumors (WHO CNS 5 classification) released in 2021 defined astrocytoma, IDH‐mutant, Grade 4.
Wenlin Chen   +21 more
doaj   +1 more source

Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue

open access: yesFrontiers in Oncology, 2023
Despite representing some of the most common and investigated molecular changes in intrahepatic cholangiocarcinoma (iCCA), the prognostic role of FGFR and IDH1/2 alterations still remains an open question. In this review we provide a critical analysis of
Giovanni Brandi   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy